Second-Site Compensatory Mutations of HIV-1 Capsid Mutations

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Virology

• Publication date

  2011-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00099-11PMID 21367891PMCID PMC3126181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA

  2010influential reference
• Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain

  2010cited by this paper
• Characterization of the in vitro HIV-1 capsid assembly pathway.

  2009cited by this paper
• Structure and assembly of immature HIV

  2009cited by this paper
• X-ray structures of the hexameric building block of the HIV capsid.

  2009influential reference
• Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function.

  2009cited by this paper
• HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate.

  2009cited by this paper
• Analysis of human immunodeficiency virus matrix domain replacements.

  2008cited by this paper
• Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity

  2007cited by this paper
• Productive Human Immunodeficiency Virus Type 1 Assembly Takes Place at the Plasma Membrane

  2007cited by this paper
• Capsid stability and replication of human immunodeficiency virus type 1 are influenced critically by charge and size of Gag residue 183.

  2007cited by this paper
• Electron cryotomography of immature HIV‐1 virions reveals the structure of the CA and SP1 Gag shells

  2007cited by this paper
• HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages

  2007cited by this paper
• Interaction between the Human Immunodeficiency Virus Type 1 Gag Matrix Domain and Phosphatidylinositol-(4,5)-Bisphosphate Is Essential for Efficient Gag Membrane Binding

  2007cited by this paper
• Structure of full-length HIV-1 CA: a model for the mature capsid lattice.

  2007cited by this paper
• Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.

  2007cited by this paper
• Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.

  2006cited by this paper
• Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus.

  2006cited by this paper
• Plasma Membrane Is the Site of Productive HIV-1 Particle Assembly

  2006cited by this paper
• A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41

  2006cited by this paper
• Analysis of Human Immunodeficiency Virus Type 1 Gag Dimerization-Induced Assembly

  2005cited by this paper
• Virus Particle Core Defects Caused by Mutations in the Human Immunodeficiency Virus Capsid N-Terminal Domain

  2005cited by this paper
• In Vitro Identification and Characterization of an Early Complex Linking HIV-1 Genomic RNA Recognition and Pr55Gag Multimerization*

  2004cited by this paper
• Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange

  2004cited by this paper
• Assembly Properties of the Human Immunodeficiency Virus Type 1 CA Protein

  2004influential reference
• The stoichiometry of Gag protein in HIV-1

  2004cited by this paper
• Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release

  2003cited by this paper
• Retrovirus capsid protein assembly arrangements.

  2003cited by this paper
• Antiviral inhibition of the HIV-1 capsid protein.

  2003cited by this paper
• Role of myristylation in HIV-1 Gag assembly.

  2003cited by this paper
• Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry.

  2003cited by this paper
• Role of ESCRT-I in Retroviral Budding

  2003cited by this paper
• Structural organization of authentic, mature HIV‐1 virions and cores

  2003cited by this paper
• Late Assembly Domain Function Can Exhibit Context Dependence and Involves Ubiquitin Residues Implicated in Endocytosis

  2002cited by this paper
• Second-Site Suppressors of Rous Sarcoma Virus CA Mutations: Evidence for Interdomain Interactions

  2001cited by this paper
• HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.

  2001cited by this paper
• Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

  2001cited by this paper
• Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1

  2000cited by this paper
• Roles of Matrix, p2, and N-Terminal Myristoylation in Human Immunodeficiency Virus Type 1 Gag Assembly

  2000cited by this paper
• Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with RNA

  2000cited by this paper
• A conformational switch controlling HIV‐1 morphogenesis

  2000cited by this paper
• Role of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly

  2000cited by this paper
• Image reconstructions of helical assemblies of the HIV-1 CA protein

  2000cited by this paper
• Assembly and analysis of conical models for the HIV-1 core.

  1999cited by this paper
• The Gag Domains Required for Avian Retroviral RNA Encapsidation Determined by Using Two Independent Assays

  1999cited by this paper
• Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein

  1999cited by this paper
• Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26.

  1999cited by this paper
• N-Terminal Extension of Human Immunodeficiency Virus Capsid Protein Converts the In Vitro Assembly Phenotype from Tubular to Spherical Particles

  1998cited by this paper
• The role of nucleocapsid of HIV-1 in virus assembly.

  1998cited by this paper
• Proteolytic refolding of the HIV‐1 capsid protein amino‐terminus facilitates viral core assembly

  1998cited by this paper
• Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes

  1997cited by this paper
• Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.

  1997cited by this paper
• Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents

  1996cited by this paper
• Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein

  1996cited by this paper
• Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1

  1995cited by this paper
• Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

  1995cited by this paper
• Structural interactions between retroviral Gag proteins examined by cysteine cross-linking

  1995cited by this paper
• Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein

  1994cited by this paper
• Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly

  1994cited by this paper
• Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1.

  1994cited by this paper
• Functional domains of the capsid protein of human immunodeficiency virus type 1

  1994cited by this paper
• Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1

  1994influential reference
• Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids

  1994cited by this paper
• Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants

  1993cited by this paper
• Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant

  1993cited by this paper
• The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions

  1992cited by this paper
• Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism

  1992cited by this paper
• Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

  1991cited by this paper
• Further studies of HIV morphology by negative staining.

  1988cited by this paper
• Electron microscopy of human immunodeficiency virus.

  1988cited by this paper
• The morphology of human immunodeficiency virus (HIV) by negative staining

  1988cited by this paper
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

  1987cited by this paper
• Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

  1986cited by this paper
• Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

  1985cited by this paper

• Pharmacokinetics, pharmacodynamics, efficacy and drug resistance selection of injectable long-acting lenacapavir pre-exposure prophylaxis (PrEP) against HIV

  2025cites this paper
• HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly

  2024cites this paper
• HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes

  2023cites this paper
• From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics.

  2023cites this paper
• Ceramide synthase 2 deletion decreases the infectivity of HIV-1

  2021influential citation
• Capsid-specific nanobody effects on HIV-1 assembly and infectivity.

  2021cites this paper
• Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail

  2020cites this paper
• Intrinsic curvature of the HIV-1 CA hexamer underlies capsid topology and interaction with cyclophilin A

  2020cites this paper
• Intrinsic curvature of the HIV-1 CA hexamer underlies capsid topology and interaction with cyclophilin A

  2020cites this paper
• Epistasis detectably alters correlations between genomic sites in a narrow parameter window

  2019cites this paper
• Authentication analysis of MT-4 cells distributed by the NIH AIDS Reagent Program 1

  2019cites this paper
• Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations

  2019cites this paper
• Authentication Analysis of MT-4 Cells Distributed by the National Institutes of Health AIDS Reagent Program

  2019cites this paper
• Functional rescue of cataract-causing αA-G98R-crystallin by targeted compensatory suppressor mutations in human αA-crystallin.

  2019cites this paper
• Sub-dominant principal components inform new vaccine targets for HIV Gag

  2019cites this paper
• Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket

  2019cites this paper
• CCR5 Inhibitors and HIV-1 Infection

  2018cites this paper
• Evolutionary footprint of epistasis

  2018cites this paper
• Analysis of K-Ras Interactions by Biotin Ligase Tagging.

  2017cites this paper
• Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein

  2017cites this paper
• Functional and Structural Characterization of Novel Type of Linker Connecting Capsid and Nucleocapsid Protein Domains in Murine Leukemia Virus*

  2016cites this paper
• Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

  2016cites this paper
• Two second-site mutations compensate the engineered mutation of R7A in vesicular stomatitis virus nucleocapsid protein.

  2016cites this paper
• CCR5: A Cellular Doorway for HIV-1 Entry

  2015cites this paper
• Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment.

  2015cites this paper
• Analysis of HIV-1 Gag Protein Interactions via Biotin Ligase Tagging

  2015influential citation
• Potential Role for CA-SP in Nucleating Retroviral Capsid Maturation

  2014cites this paper
• Allosteric modulation of protein oligomerization: an emerging approach to drug design

  2014cites this paper
• HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

  2014cites this paper
• RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release.

  2014influential citation
• The retrovirus MA and PreTM proteins follow immature MLV cores.

  2013cites this paper
• The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid

  2013cites this paper
• Virus Assembly as a Target for Antiretroviral Therapy

  2013cites this paper
• Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase

  2013cites this paper
• Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.

  2013influential citation
• This information is current as Infection Multiple Immune Responses Control an HIV The Rate of Immune Escape Vanishes When

  2013cites this paper
• Complete Genome Sequence of a UL96 Mutant Cytomegalovirus Towne-BAC (Bacterial Artificial Chromosome) Isolate Passaged in Fibroblasts To Allow Accumulation of Compensatory Mutations

  2013cites this paper
• Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid

  2012cites this paper
• Analysis of Small Molecule Ligands Targeting the HIV-1 Matrix Protein-RNA Binding Site*

  2012cites this paper
• Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects

  2012cites this paper
• Rationally Designed Interfacial Peptides Are Efficient In Vitro Inhibitors of HIV-1 Capsid Assembly with Antiviral Activity

  2011cites this paper